SCHEMBL28810491

SCHEMBL28810491

CC(C)(C)OC(=O)N1CC2CCC(C1)N2c1nccc(OCCN2CCN(C(=O)OCc3ccccc3)CC2)n1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 1/20 0.46
▸ GPR119 Q8TDV5 3/20 0.44
▸ PARP1 P09874 2/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ TLR9 Q9NR96 1/20 0.40
▸ TLR7 Q9NYK1 1/20 0.40
▸ GRIN2B Q13224 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ ACKR3 P25106 2/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ FAAH O00519 1/20 0.39
▸ TNKS O95271 1/20 0.38
▸ TNKS2 Q9H2K2 1/20 0.38
▸ PARP2 Q9UGN5 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29943772 1.00 ACHE (0.46) ACHEGPR119PARP1MEN1KMT2A
SCHEMBL23301259 0.90 GRIN2B (0.42) PARP1MEN1KMT2AGRIN2BNPC1
SCHEMBL21405122 0.88 GPR119 (0.41) ACHEGPR119PARP1MEN1KMT2A
SCHEMBL29790292 0.88 GPR119 (0.41) ACHEGPR119PARP1MEN1KMT2A
SCHEMBL29942509 0.85 TNKS (0.43) PARP1MEN1KMT2AGRIN2BHTT
SCHEMBL23301181 0.85 TNKS (0.43) PARP1MEN1KMT2AGRIN2BHTT
SCHEMBL30796848 0.85 ACHE (0.53) ACHEGPR119MEN1KMT2ATLR9
SCHEMBL23301381 0.83 ALDH1A1 (0.46) GPR119PARP1MEN1KMT2AHTT
SCHEMBL30796962 0.83 PRMT5 (0.50) ACHEGPR119GRIN2BHTTNPC1
SCHEMBL29910587 0.83 KDM4E (0.47) GPR119HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114728936-A Bifunctional compounds for the treatment of cancer 豪夫迈·罗氏有限公司 2022-07-08 — — CN disclosed
Send feedback